Advancing AML Biomarker Discovery with Multi-omic Analysis
Alexis L. Santana, PhD - Champions Oncology & Guanghui Han, PhD - BGI San Jose Mass Spectrometry Center
About this talk
Champions Oncology is illuminating the cellular dynamics of cancer by using our revolutionary Lumin Bioinformatics Platform to re-discover your data. With the recent addition of proteomics datasets in partnership with BGI Americas, Champions is able to enhance further characterization of our proprietary PDX bank datasets, in conjunction with public datasets within the Lumin Bioinformatics Platform. In this webinar, case studies will be presented to demonstrate the many different ways to use our new proteomics dataset in primary patient AML models, which can be used to explore mechanisms of resistance and develop biomarker hypotheses.
What will you learn by attending this webinar?
• Explore proteomics datasets within Lumin to gain a deeper understanding of your therapeutic response
• Review case studies exploring biomarkers of sensitivity and resistance, including our new AML proteomics datasets
• Investigate gene signatures and biomarker pathways to discover new hypotheses in AML disease
• Proteomics and multiomics solutions for biopharma applications
Champions Oncology delivers innovative solutions to oncology drug development, accelerating the journey from the research bench to the clinic – decreasing timelines, lowering costs, and ultimately saving patient lives. Learn more about Champions Oncology's capabilities, our service platforms and educational topics affecting our industry on our Webinar Channel.…